{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:44:24Z","timestamp":1790714664611,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Measles is an acute and highly contagious but vaccine-preventable infectious disease. Despite years of being considered eliminated, decreased vaccination rates have produced virus reemergence in several countries, including Brazil. Measles can be controlled through immunization programs, through which aim to achieve 95% coverage with two doses of the vaccine. Measles can also be controlled if suspected cases can be properly identified in order to contain outbreaks. This cross-sectional study determined the prevalence of measles antibodies and their correlation with rubella antibodies (resulting from the combination vaccine used in Brazil\u2019s public immunization program) in individuals aged higher 10 years old in S\u00e3o Jos\u00e9 do Rio Preto, S\u00e3o Paulo State, Brazil, participants of a prospective cohort of arbovirosis surveillance before virus reemergence in the country. Our findings presented that 32.9% of individuals aged 10\u201340 years old had not antibodies against measles; 39.3% of total individuals with documented evidence of measles vaccination did not have anti-measles IgG, though only 20.2% of individuals with documented evidence of rubella vaccination lacked anti-rubella IgG. Besides, the most of measles cases reported in the city, following the virus spreading in the country, occurred especially in groups defined by us as susceptible. Because the combination MMR vaccine is part of Brazil\u2019s national vaccine schedule, the possible reasons for this relatively high rate of seronegativity need to be investigated further, once that it reflects outbreak risk.<\/jats:p>","DOI":"10.1038\/s41598-020-62151-3","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T11:03:20Z","timestamp":1584702200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prevalence of Measles Antibodies in S\u00e3o Jos\u00e9 do Rio Preto, S\u00e3o Paulo, Brazil: A serological survey model"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7324-1591","authenticated-orcid":false,"given":"Cassia Fernanda","family":"Estofolete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Henrique Gon\u00e7alves de Aguiar","family":"Milhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Cunha Galv\u00e3o de","family":"Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gislaine Celestino Dutra da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Tayar","family":"Augusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Bernardes","family":"Terzian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia","family":"Zini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edison Lu\u00eds","family":"Durigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Bruna Leal","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Massad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1102-2419","authenticated-orcid":false,"given":"Mauricio Lacerda","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"62151_CR1","unstructured":"Gershon, A. Measles in Harrison\u2019s principles of internal medicine (eds. Braunwald, E. et al.) Ch. 176, (McGraw-Hill, 2005)."},{"key":"62151_CR2","unstructured":"Mandell, G L. & Raphael Dolin, J. E. B. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases. 7th edn, (2010)."},{"key":"62151_CR3","first-page":"283","volume":"82","author":"M Abbas","year":"2007","unstructured":"Abbas, M., Atwa, M. & Emara, A. Seroprevalence of measles, mumps, rubella and varicella among staff of a hospital in Riyadh, Saudi Arabia. J Egypt Public Health Assoc 82, 283\u2013297 (2007).","journal-title":"J Egypt Public Health Assoc"},{"key":"62151_CR4","unstructured":"WHO. WHO Guideline for Epemidemic Preparedness and Response to Measles Outbreak. (World Health Organization, Geneva, Switzerland, 1999)."},{"key":"62151_CR5","doi-asserted-by":"crossref","unstructured":"Shamsizadeh, A. et al. Seroprevalence of measles, mumps and rubella Antibodies in 18 months and 6.5 years old children: 6 months after measles-mumps-rubella (MMR) vaccination. Jundishapur J Microbiol 5, 578\u2013581(2012).","DOI":"10.5812\/jjm.4563"},{"key":"62151_CR6","doi-asserted-by":"crossref","unstructured":"Sharma, H. J. et al. Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India. Journal of infection in developing countries 5, 874-881 (2011).","DOI":"10.3855\/jidc.1847"},{"key":"62151_CR7","unstructured":"dos Santos, E. Epidmemiologia do sarampo no Brasil in Epidemiologia: contextos e pluralidade [online] (ed. Veras, R. P.). Epidemiologica series, n 4 (1998)."},{"key":"62151_CR8","doi-asserted-by":"crossref","unstructured":"Domingues, C. M., Teixeira, A. M. & Carvalho, S. M. National immunization program: vaccination, compliance and pharmacovigilance. Revista do Instituto de Medicina Tropical de Sao Paulo 54(Suppl 18), S22\u201327 (2012).","DOI":"10.1590\/S0036-46652012000700009"},{"key":"62151_CR9","doi-asserted-by":"crossref","unstructured":"Guerra, F. M. et al. The basic reproduction number (R0) of measles: a systematic review. The Lancet. Infectious diseases 17, e420-e42 (2017).","DOI":"10.1016\/S1473-3099(17)30307-9"},{"key":"62151_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3399\/bjgp18X697961","volume":"68","author":"M Moten","year":"2018","unstructured":"Moten, M., Phillips, A., Saliba, V., Harding, N. & Sibal, B. Measles: is it still a threat? Br J Gen Pract 68, 404\u2013405 (2018).","journal-title":"Br J Gen Pract"},{"key":"62151_CR11","unstructured":"Brasil. Plano de Conting\u00eancia para Resposta \u00e0s Emerg\u00eancias de Sa\u00fade P\u00fablica: sarampo [recurso eletr\u00f4nico] (ed. Departamento de Vigil\u00e2ncia das Doen\u00e7as Transmiss\u00edveis) (2016)."},{"key":"62151_CR12","unstructured":"PAHO. Plan of action for maintaining measles, rubella, and congenital rubella syndrome elimination in the region of the Americas: final report (ed PAHO) (2016)."},{"key":"62151_CR13","unstructured":"PAHO. Epidemiological update measles. (PAHO, 2018)."},{"key":"62151_CR14","unstructured":"SES-SP. Sarampo - Boletim epidemiologico. Agosto 2019. (ed. Centro de Vigil\u00e2ncia Epidemiol\u00f3gica. Prof. Alexandre Vranjac), (S\u00e3o Paulo, 2019)."},{"key":"62151_CR15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1590\/S0034-89102005000300016","volume":"39","author":"A Mondini","year":"2005","unstructured":"Mondini, A., Chiaravalloti Neto, F., Gallo y Sanches, M. & Lopes, J. C. Spatial analysis of dengue transmission in a medium-sized city in Brazil. Rev Saude Publica 39, 444\u2013451 (2005).","journal-title":"Rev Saude Publica"},{"key":"62151_CR16","unstructured":"CVE. Boletim Epidemiol\u00f3gico de Febre Amarela. 19\/03\/2018. (ed. Divis\u00e3o de Zoonoses e Central. Centro de Vigil\u00e2ncia Epidemiol\u00f3gica Prof. Alexandre Vranjac, S\u00e3o Paulo, 2018)."},{"key":"62151_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3201\/eid1301.060905","volume":"13","author":"A Mondini","year":"2007","unstructured":"Mondini, A. et al. Saint Louis encephalitis virus, Brazil. Emerging infectious diseases 13, 176\u2013178 (2007).","journal-title":"Emerging infectious diseases"},{"key":"62151_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jcv.2016.05.012","volume":"81","author":"C Fernanda Estofolete","year":"2016","unstructured":"Fernanda Estofolete, C. et al. Clinical and laboratory profile of Zika virus infection in dengue suspected patients: A case series. J Clin Virol 81, 25\u201330 (2016).","journal-title":"J Clin Virol"},{"key":"62151_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jcv.2007.06.007","volume":"40","author":"A Mondini","year":"2007","unstructured":"Mondini, A. et al. Simultaneous infection by DENV-3 and SLEV in Brazil. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 40, 84\u201386 (2007).","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"key":"62151_CR20","unstructured":"SMS. Boletim de Sarampo. Ano de primeiros sintomas: 2019. S\u00e3o Jos\u00e9 do Rio Preto, http:\/\/saude.riopreto.sp.gov.br\/transparencia\/boletim_sarampo_saude_ riopreto.php (2020)."},{"key":"62151_CR21","unstructured":"Brasil. Cobertura por Imuno segundo Ano. S\u00e3o Jose do Rio Preto. (ed. DataSUS. Programa Nacional de Imuniza\u00e7\u00f5es) (2019)."},{"key":"62151_CR22","unstructured":"Brasil. Coberturas vacinais por Imuno segundo Ano. (ed. DataSUS. Programa Nacional de Imuniza\u00e7\u00f5es, 2019)."},{"key":"62151_CR23","first-page":"1","volume":"62","author":"HQ McLean","year":"2013","unstructured":"McLean, H. Q., Fiebelkorn, A. P., Temte, J. L., Wallace, G. S. & Prevention, Cf. D. Ca Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62, 1\u201334 (2013).","journal-title":"MMWR Recomm Rep"},{"key":"62151_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1056\/NEJMcp1905181","volume":"381","author":"PM Strebel","year":"2019","unstructured":"Strebel, P. M. & Orenstein, W. A. Measles. The New England journal of medicine 381, 349\u2013357 (2019).","journal-title":"The New England journal of medicine"},{"key":"62151_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1089\/vim.2015.0070","volume":"29","author":"DJ Gohil","year":"2016","unstructured":"Gohil, D. J. et al. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India. Viral Immunol 29, 159\u2013163 (2016).","journal-title":"Viral Immunol"},{"key":"62151_CR26","doi-asserted-by":"publisher","first-page":"ofv006","DOI":"10.1093\/ofid\/ofv006","volume":"2","author":"EJ Lebo","year":"2015","unstructured":"Lebo, E. J. et al. Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009-2010. Open Forum Infect Dis 2, ofv006 (2015).","journal-title":"Open Forum Infect Dis"},{"key":"62151_CR27","doi-asserted-by":"crossref","unstructured":"Strebel, P., Papania, M., Gastanaduy, P. & Goodson, J. Measles vaccine in Vaccines (ed. Orenstein, W. A. Plotkin, S. A. & Offit, P. A.) (Elsevier, 2018).","DOI":"10.1016\/B978-0-323-35761-6.00037-7"},{"key":"62151_CR28","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1016\/j.vaccine.2019.07.049","volume":"37","author":"S Carryn","year":"2019","unstructured":"Carryn, S., Feyssaguet, M., Povey, M. & Di Paolo, E. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up. Vaccine 37, 5323\u20135331 (2019).","journal-title":"Vaccine"},{"key":"62151_CR29","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1016\/j.vaccine.2012.05.015","volume":"30","author":"S Wicker","year":"2012","unstructured":"Wicker, S. & Poland, G. A. Measles vaccination in health care personnel: mandates, ethics, and patient safety. Vaccine 30, 4407\u20134408 (2012).","journal-title":"Vaccine"},{"key":"62151_CR30","unstructured":"SMS. Painel de Monitoramento, 2015. Indicadores de 2014. (ed. Secretaria Municipal de Sa\u00fade. Ger\u00eancia de Informa\u00e7\u00f5es de Vigil\u00e2ncia Sanit\u00e1ria, S\u00e3o Jos\u00e9 do Rio Preto, 2015)."},{"key":"62151_CR31","unstructured":"SMS. Painel de Monitoramento, 2016. Indicadores de 2015. (ed. Secretaria de Saude de S\u00e3o Jose do Rio Preto, S\u00e3o Jos\u00e9 do Rio Preto, 2016)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62151-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62151-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62151-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:51:49Z","timestamp":1670316709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62151-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62151"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62151-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]},"assertion":[{"value":"7 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5179"}}